Paul Bao
Corporate Officer/Principal chez Ohmx Corp.
Profil
Paul Bao currently works at Ohmx Corp., as Vice President-Product Development from 2011.
Dr. Bao also formerly worked at Corning, Inc., as Manager-Biochemistry Department and Nanosphere, Inc., as Senior Manager & Head-Assay Research.
Dr. Bao received his doctorate degree from The University of Texas at Austin, graduate degree from Virginia Polytechnic Institute & State University, and undergraduate degree from Zhejiang University.
Postes actifs de Paul Bao
| Sociétés | Poste | Début |
|---|---|---|
Ohmx Corp.
 Ohmx Corp. SemiconductorsElectronic Technology Ohmx Corp. develops bioelectronic detection devices. Its products include biosensor chip, portable point-of-care (POC) system, and prostate cancer aggressiveness biomaker. The company was founded by Thomas J. Meade on October 25, 2004 and is headquartered in Evanston, IL. | Corporate Officer/Principal | 24/03/2011 |
Anciens postes connus de Paul Bao
| Sociétés | Poste | Fin |
|---|---|---|
| NANOSPHERE, INC. | Corporate Officer/Principal | - |
| CORNING INCORPORATED | Corporate Officer/Principal | - |
Formation de Paul Bao
| The University of Texas at Austin | Doctorate Degree |
| Zhejiang University | Undergraduate Degree |
| Virginia Polytechnic Institute & State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CORNING INCORPORATED | Electronic Technology |
| Entreprise privées | 2 |
|---|---|
Ohmx Corp.
Ohmx Corp. SemiconductorsElectronic Technology Ohmx Corp. develops bioelectronic detection devices. Its products include biosensor chip, portable point-of-care (POC) system, and prostate cancer aggressiveness biomaker. The company was founded by Thomas J. Meade on October 25, 2004 and is headquartered in Evanston, IL. | Electronic Technology |
Nanosphere, Inc.
 Nanosphere, Inc. Medical SpecialtiesHealth Technology Nanosphere, Inc. engages in the development, manufacture, and market of molecular diagnostics platform. Its platform, Verigene System, enables clinicians to identify and treat bacteria and viruses responsible for some of the most complex, costly, and deadly infectious diseases. The company was founded by Chad A. Mirkin and Robert Letsinger on December 30, 1999 and is headquartered in Northbrook, IL. | Health Technology |
